MedTrace Logo

The Effectiveness of the LCP in Improving End of Life Care for Dying Cancer Patients in Hospital.

NCT01081899 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 308

Last updated 2013-01-14

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effectiveness of the LCP-I Program in improving the quality of end-of-life care provided to cancer patients who die on hospital medical wards as compared to standard healthcare practices.

Conditions

Interventions

OTHER

The LCP-I Program

The LCP-I Program is a continuous quality Improvement Program of end-of-life care implemented by a Palliative Care Unit (PCU) in a hospital Medical Ward.

Sponsors & Collaborators

  • Regional Palliative Care Network

    lead OTHER

Principal Investigators

  • Massimo Costantini, MD · National Cancer Research Institute - Genoa (Italy)

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2012-10-31
Completion
2012-10-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01081899 on ClinicalTrials.gov